Seeing Is Believing
NVCT is currently covered by 1 analysts with an average price target of $21.38. This is a potential upside of $14.38 (205.43%) from yesterday's end of day stock price of $7.
Nuvectis Pharma's activity chart (see below) currently has 3 price targets and 7 ratings on display. The stock rating distribution of NVCT is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 14.29% with an average time for these price targets to be met of 65 days.
Highest price target for NVCT is $21, Lowest price target is $21, average price target is $21.38.
Most recent stock forecast was given by JOSEPH PANTGINIS from HC WAINWRIGHT on 06-Aug-2024. First documented stock forecast 02-Mar-2022.
Currently out of the existing stock ratings of NVCT, 5 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$21
$14.24 (210.65%)
$21
5 months 29 days ago
(06-Aug-2024)
1/7 (14.29%)
$14.38 (217.22%)
65
What is NVCT (Nuvectis Pharma) average time for price targets to be met?
Which analyst has the current highest performing score on NVCT (Nuvectis Pharma) with a proven track record?
Which analyst has the most public recommendations on NVCT (Nuvectis Pharma)?
Which analyst is the currently most bullish on NVCT (Nuvectis Pharma)?